MoneyWorks4Me

Molbio Diagnostics informs about disclosure

13 Oct 2026 Evaluate
Molbio Diagnostics has informed that the exchange has received the disclosure under Regulation 29(1) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Kotak Mahindra Mutual Fund. 

The above information is a part of company’s filings submitted to BSE. 

Peers
Company Name CMP
Lenskart Solutions 631.80
Poly Medicure 1465.10
Molbio Diagnostics 1322.10
Laxmi Dental 178.00
GKB Ophthalmics 59.82
View more..